Cohort profile: the ESC EURObservational Research Programme Non-ST-segment elevation myocardial infraction (NSTEMI) Registry.

The European Society of Cardiology (ESC) EURObservational Research Programme (EORP) Non-ST-segment elevation myocardial infarction (NSTEMI) Registry aims to identify international patterns in NSTEMI management in clinical practice and outcomes against the 2015 ESC Guidelines for the management of ac...

ver descrição completa

Detalhes bibliográficos
Autores: Nadarajah, Ramesh, Ludman, Peter, Appelman, Yolande, Brugaletta, Salvatore, Budaj, Andrzej, Bueno, Hector, Huber, Kurt, Kunadian, Vijay, Leonardi, Sergio, Lettino, Maddalena, Milasinovic, Dejan, Gale, Chris P
Tipo de documento: artigo
Data de publicação:2022
País:España
Recursos:Instituto de Salud Carlos III (ISCIII)
Repositório:Repisalud
Idioma:inglês
OAI Identifier:oai:repisalud.isciii.es:20.500.12105/15841
Acesso em linha:http://hdl.handle.net/20.500.12105/15841
Access Level:Acceso aberto
Palavra-chave:Angiotensin Receptor Antagonists
Non-ST Elevated Myocardial Infarction
Adult
Humans
Hospital Mortality
Angiotensin-Converting Enzyme Inhibitors
Registries
Aspirin
id ES_dcaee6d6bf4a3f851ea8588094e2c88b
oai_identifier_str oai:repisalud.isciii.es:20.500.12105/15841
network_acronym_str ES
network_name_str España
repository_id_str
spelling Cohort profile: the ESC EURObservational Research Programme Non-ST-segment elevation myocardial infraction (NSTEMI) Registry.Nadarajah, RameshLudman, PeterAppelman, YolandeBrugaletta, SalvatoreBudaj, AndrzejBueno, HectorHuber, KurtKunadian, VijayLeonardi, SergioLettino, MaddalenaMilasinovic, DejanGale, Chris PAngiotensin Receptor AntagonistsNon-ST Elevated Myocardial InfarctionAdultHumansHospital MortalityAngiotensin-Converting Enzyme InhibitorsRegistriesAspirinThe European Society of Cardiology (ESC) EURObservational Research Programme (EORP) Non-ST-segment elevation myocardial infarction (NSTEMI) Registry aims to identify international patterns in NSTEMI management in clinical practice and outcomes against the 2015 ESC Guidelines for the management of acute coronary syndromes in patients presenting without ST-segment-elevation. Consecutively hospitalised adult NSTEMI patients (n = 3620) were enrolled between 11 March 2019 and 6 March 2021, and individual patient data prospectively collected at 287 centres in 59 participating countries during a two-week enrolment period per centre. The registry collected data relating to baseline characteristics, major outcomes (in-hospital death, acute heart failure, cardiogenic shock, bleeding, stroke/transient ischaemic attack, and 30-day mortality) and guideline-recommended NSTEMI care interventions: electrocardiogram pre- or in-hospital, pre-hospitalization receipt of aspirin, echocardiography, coronary angiography, referral to cardiac rehabilitation, smoking cessation advice, dietary advice, and prescription on discharge of aspirin, P2Y12 inhibition, angiotensin converting enzyme inhibitor (ACEi)/angiotensin receptor blocker (ARB), beta-blocker, and statin. The EORP NSTEMI Registry is an international, prospective registry of care and outcomes of patients treated for NSTEMI, which will provide unique insights into the contemporary management of hospitalised NSTEMI patients, compliance with ESC 2015 NSTEMI Guidelines, and identify potential barriers to optimal management of this common clinical presentation associated with significant morbidity and mortality.Oxford University PressAbbottAmgenAstraZenecaBayer Healthcare Pharmaceuticals-Bayer Pharma AGBoehringer Ingelheim FondsBristol-Myers SquibbPfizerDaiichi SankyoEli LillyGrupo MenariniNovartisSanofiServier20232023-04-1820222022-12-1320222022-12-13journal articlehttp://purl.org/coar/resource_type/c_6501VoRhttp://purl.org/coar/version/c_970fb48d4fbd8a85info:eu-repo/semantics/articleapplication/pdfhttp://hdl.handle.net/20.500.12105/15841reponame:Repisaludinstname:Instituto de Salud Carlos III (ISCIII)Inglésengopen accesshttp://purl.org/coar/access_right/c_abf2Atribución 4.0 Internacionalhttp://creativecommons.org/licenses/by/4.0/info:eu-repo/semantics/openAccessoai:repisalud.isciii.es:20.500.12105/158412026-06-12T12:43:37Z
dc.title.none.fl_str_mv Cohort profile: the ESC EURObservational Research Programme Non-ST-segment elevation myocardial infraction (NSTEMI) Registry.
title Cohort profile: the ESC EURObservational Research Programme Non-ST-segment elevation myocardial infraction (NSTEMI) Registry.
spellingShingle Cohort profile: the ESC EURObservational Research Programme Non-ST-segment elevation myocardial infraction (NSTEMI) Registry.
Nadarajah, Ramesh
Angiotensin Receptor Antagonists
Non-ST Elevated Myocardial Infarction
Adult
Humans
Hospital Mortality
Angiotensin-Converting Enzyme Inhibitors
Registries
Aspirin
title_short Cohort profile: the ESC EURObservational Research Programme Non-ST-segment elevation myocardial infraction (NSTEMI) Registry.
title_full Cohort profile: the ESC EURObservational Research Programme Non-ST-segment elevation myocardial infraction (NSTEMI) Registry.
title_fullStr Cohort profile: the ESC EURObservational Research Programme Non-ST-segment elevation myocardial infraction (NSTEMI) Registry.
title_full_unstemmed Cohort profile: the ESC EURObservational Research Programme Non-ST-segment elevation myocardial infraction (NSTEMI) Registry.
title_sort Cohort profile: the ESC EURObservational Research Programme Non-ST-segment elevation myocardial infraction (NSTEMI) Registry.
dc.creator.none.fl_str_mv Nadarajah, Ramesh
Ludman, Peter
Appelman, Yolande
Brugaletta, Salvatore
Budaj, Andrzej
Bueno, Hector
Huber, Kurt
Kunadian, Vijay
Leonardi, Sergio
Lettino, Maddalena
Milasinovic, Dejan
Gale, Chris P
author Nadarajah, Ramesh
author_facet Nadarajah, Ramesh
Ludman, Peter
Appelman, Yolande
Brugaletta, Salvatore
Budaj, Andrzej
Bueno, Hector
Huber, Kurt
Kunadian, Vijay
Leonardi, Sergio
Lettino, Maddalena
Milasinovic, Dejan
Gale, Chris P
author_role author
author2 Ludman, Peter
Appelman, Yolande
Brugaletta, Salvatore
Budaj, Andrzej
Bueno, Hector
Huber, Kurt
Kunadian, Vijay
Leonardi, Sergio
Lettino, Maddalena
Milasinovic, Dejan
Gale, Chris P
author2_role author
author
author
author
author
author
author
author
author
author
author
dc.contributor.none.fl_str_mv Abbott
Amgen
AstraZeneca
Bayer Healthcare Pharmaceuticals-Bayer Pharma AG
Boehringer Ingelheim Fonds
Bristol-Myers Squibb
Pfizer
Daiichi Sankyo
Eli Lilly
Grupo Menarini
Novartis
Sanofi
Servier
dc.subject.none.fl_str_mv Angiotensin Receptor Antagonists
Non-ST Elevated Myocardial Infarction
Adult
Humans
Hospital Mortality
Angiotensin-Converting Enzyme Inhibitors
Registries
Aspirin
topic Angiotensin Receptor Antagonists
Non-ST Elevated Myocardial Infarction
Adult
Humans
Hospital Mortality
Angiotensin-Converting Enzyme Inhibitors
Registries
Aspirin
description The European Society of Cardiology (ESC) EURObservational Research Programme (EORP) Non-ST-segment elevation myocardial infarction (NSTEMI) Registry aims to identify international patterns in NSTEMI management in clinical practice and outcomes against the 2015 ESC Guidelines for the management of acute coronary syndromes in patients presenting without ST-segment-elevation. Consecutively hospitalised adult NSTEMI patients (n = 3620) were enrolled between 11 March 2019 and 6 March 2021, and individual patient data prospectively collected at 287 centres in 59 participating countries during a two-week enrolment period per centre. The registry collected data relating to baseline characteristics, major outcomes (in-hospital death, acute heart failure, cardiogenic shock, bleeding, stroke/transient ischaemic attack, and 30-day mortality) and guideline-recommended NSTEMI care interventions: electrocardiogram pre- or in-hospital, pre-hospitalization receipt of aspirin, echocardiography, coronary angiography, referral to cardiac rehabilitation, smoking cessation advice, dietary advice, and prescription on discharge of aspirin, P2Y12 inhibition, angiotensin converting enzyme inhibitor (ACEi)/angiotensin receptor blocker (ARB), beta-blocker, and statin. The EORP NSTEMI Registry is an international, prospective registry of care and outcomes of patients treated for NSTEMI, which will provide unique insights into the contemporary management of hospitalised NSTEMI patients, compliance with ESC 2015 NSTEMI Guidelines, and identify potential barriers to optimal management of this common clinical presentation associated with significant morbidity and mortality.
publishDate 2022
dc.date.none.fl_str_mv 2022
2022-12-13
2022
2022-12-13
2023
2023-04-18
dc.type.none.fl_str_mv journal article
http://purl.org/coar/resource_type/c_6501
VoR
http://purl.org/coar/version/c_970fb48d4fbd8a85
dc.type.openaire.fl_str_mv info:eu-repo/semantics/article
format article
dc.identifier.none.fl_str_mv http://hdl.handle.net/20.500.12105/15841
url http://hdl.handle.net/20.500.12105/15841
dc.language.none.fl_str_mv Inglés
eng
language_invalid_str_mv Inglés
language eng
dc.rights.none.fl_str_mv open access
http://purl.org/coar/access_right/c_abf2
Atribución 4.0 Internacional
http://creativecommons.org/licenses/by/4.0/
dc.rights.openaire.fl_str_mv info:eu-repo/semantics/openAccess
rights_invalid_str_mv open access
http://purl.org/coar/access_right/c_abf2
Atribución 4.0 Internacional
http://creativecommons.org/licenses/by/4.0/
eu_rights_str_mv openAccess
dc.format.none.fl_str_mv application/pdf
dc.publisher.none.fl_str_mv Oxford University Press
publisher.none.fl_str_mv Oxford University Press
dc.source.none.fl_str_mv reponame:Repisalud
instname:Instituto de Salud Carlos III (ISCIII)
instname_str Instituto de Salud Carlos III (ISCIII)
reponame_str Repisalud
collection Repisalud
repository.name.fl_str_mv
repository.mail.fl_str_mv
_version_ 1869421791225577472
score 15,812429

Registros relacionados